References
- Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS, Khasraw M. Management of glioblastoma: state of the art and future directions. CA A Cancer J Clin. 2020;70(4):299–312. doi:https://doi.org/10.3322/caac.21613
- Chang E, Patel CB, Pohling C, Young C, Song J, Flores TA, Zeng Y, Joubert L-M, Arami H, Natarajan A, et al. Tumor treating fields increases membrane permeability in glioblastoma cells. Cell Death Discov. 2018;4:113: doi:https://doi.org/10.1038/s41420-018-0130-x
- Lim M, Xia Y, Bettegowda C, Weller M. Current state of immunotherapy for glioblastoma. Nat Rev Clin Oncol. 2018;15(7):422–42. doi:https://doi.org/10.1038/s41571-018-0003-5
- Sampson JH, Gunn MD, Fecci PE, Ashley DM. Brain immunology and immunotherapy in brain tumours. Nat Rev Cancer. 2020;20(1):12–25. doi:https://doi.org/10.1038/s41568-019-0224-7
- Rafeeq M, Murad HAS, Abdallah HM, El-Halawany AM. Protective effect of 6-paradol in acetic acid-induced ulcerative colitis in rats. BMC Complement Med Ther. 2021;21(1):28. doi:https://doi.org/10.1186/s12906-021-03203-7
- Lee E, Surh YJ. Induction of apoptosis in HL-60 cells by pungent vanilloids, [6]-gingerol and [6]-paradol. Cancer Lett. 1998;134(2):163–8. doi:https://doi.org/10.1016/S0304-3835(98)00253-5
- Keum YS, Kim J, Lee KH, Park KK, Surh YJ, Lee JM, Lee SS, Yoon JH, Joo SY, Cha IH, et al. Induction of apoptosis and caspase-3 activation by chemopreventive [6]-paradol and structurally related compounds in KB cells. Cancer Lett. 2002;177(1):41–7.: doi:https://doi.org/10.1016/s0304-3835(01)00781-9
- Chung WY, Jung YJ, Surh YJ, Lee SS, Park KK. Antioxidative and antitumor promoting effects of [6]-paradol and its homologs. Mutat Res. 2001;496(1–2):199–206. doi:https://doi.org/10.1016/s1383-5718(01)00221-2
- Kaewtunjai N, Wongpoomchai R, Imsumran A, Pompimon W, Athipornchai A, Suksamrarn A, Lee TR, Tuntiwechapikul W. Ginger extract promotes telomere shortening and cellular senescence in A549 lung cancer cells. ACS Omega. 2018;3(12):18572–81. doi:https://doi.org/10.1021/acsomega.8b02853
- Sharif F, Azirudin A, Saedudin RDR, Mohd Yunus A, Abdul Hamid AA, et al. Molecular docking analysis of 6-paradol, zingerone and zerumbone against human estrogen receptor alpha (ERɑ). Int J Integr Eng. 2018;10(6):113–8. doi:https://doi.org/10.30880/ijie.2018.10.06.015
- Mariadoss AV, Kathiresan S, Muthusamy R, Kathiresan S. Protective effects of [6]-paradol on histological lesions and immunohistochemical gene expression in DMBA induced hamster buccal pouch carcinogenesis. Asian Pac J Cancer Prev. 2013;14(5):3123–9. doi:https://doi.org/10.7314/apjcp.2013.14.5.3123
- Li Q, Wang R, Wang L, Li L, Zhang D. Paradol inhibits proliferation and migration of human hepatocellular carcinoma cells. Sci Adv Mater. 2019;11(10):1467–73. doi:https://doi.org/10.1166/sam.2019.3555
- Zhang D, Li C, Li B, Wang Y, Chen Z, Xu L, Liu T. Cannabisin G from Sinomenium acutum induces apoptosis in human glioblastoma cells. Sci Adv Mater. 2020;12(6):823–8. doi:https://doi.org/10.1166/sam.2020.3743
- Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles’ heel? Nat Rev Cancer. 2014;14(11):709–21. doi:https://doi.org/10.1038/nrc3803
- Broekman ML, Maas SLN, Abels ER, Mempel TR, Krichevsky AM, Breakefield XO. Multidimensional communication in the microenvirons of glioblastoma. Nat Rev Neurol. 2018;14(8):482–95. doi:https://doi.org/10.1038/s41582-018-0025-8
- Muller Bark J, Kulasinghe A, Chua B, Day BW, Punyadeera C. Circulating biomarkers in patients with glioblastoma. Br J Cancer. 2020;122(3):295–305. doi:https://doi.org/10.1038/s41416-019-0603-6
- Shukla Y, Singh M. Cancer preventive properties of ginger: a brief review. Food Chem Toxicol. 2007;45(5):683–90. doi:https://doi.org/10.1016/j.fct.2006.11.002
- Sapkota A, Park SJ, Choi JW. Neuroprotective effects of 6-Shogaol and its metabolite, 6-Paradol, in a mouse model of multiple sclerosis. Biomol Ther (Seoul)). 2019;27(2):152–9. doi:https://doi.org/10.4062/biomolther.2018.089
- Abdel-Naim A, Alghamdi A, Algandaby M, Al-Abbasi F, Al-Abd A, Abdallah H, El-Halawany A, Hattori M. Phenolics isolated from Aframomum meleguta enhance proliferation and ossification markers in bone cells. Molecules. 2017;22(9):1467. doi:https://doi.org/10.3390/molecules2209
- Yamaguchi K, Mitsunaga T, Yamauchi K. 6-Paradol and its glucoside improve memory disorder in mice. Food Funct. 2020;11(11):9892–902. doi:https://doi.org/10.1039/d0fo01975e
- Fajrin FA, Rahmayanti F, Pratoko DK. The binding prediction of 6-paradol and its derivatives on TRPV1 agonist as a new compound for treating painful diabetic neuropathy. J I Dasar. 2020;21(2):133–8. doi:https://doi.org/10.19184/jid.v21i2.15501
- Kiyama R. Nutritional implications of ginger: chemistry, biological activities and signaling pathways. J Nutr Biochem. 2020;86:108486. doi:https://doi.org/10.1016/j.jnutbio.2020.108486
- Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 2007;26(22):3291–310. doi:https://doi.org/10.1038/sj.onc.1210422
- Cagnol S, Chambard JC. ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J. 2010;277(1):2–21. doi:https://doi.org/10.1111/j.1742-4658.2009.07366.x
- Lev N, Ickowicz D, Barhum Y, Blondheim N, Melamed E, Offen D. Experimental encephalomyelitis induces changes in DJ-1: implications for oxidative stress in multiple sclerosis. Antioxid Redox Signal. 2006;8(11–12):1987–95. doi:https://doi.org/10.1089/ars.2006.8.1987
- Haddad AF, Young JS, Amara D, Berger MS, Raleigh DR, Aghi MK, Butowski NA. Mouse models of glioblastoma for the evaluation of novel therapeutic strategies. Neurooncol Adv. 2021;3(1):vdab100. doi:https://doi.org/10.1093/noajnl/vdab100
- Kargiotis O, Chetty C, Gondi CS, Tsung AJ, Dinh DH, Gujrati M, Lakka SS, Kyritsis AP, Rao JS. Adenovirus-mediated transfer of siRNA against MMP-2 mRNA results in impaired invasion and tumor-induced angiogenesis, induces apoptosis in vitro and inhibits tumor growth in vivo in glioblastoma. Oncogene. 2008;27(35):4830–40. doi:https://doi.org/10.1038/onc.2008.122